Second, before declaring patients in remission, Penn doctors scoured especially hard for errant leukemia cells. Penn will now work with other medical centers to test the therapy in more patients, and they plan to try the therapy out in other types of blood cancers and later in solid tumors. He says he'll never forget the first patient he treated, who initially had an enormous amount of cancer cells in his bone marrow. "This is absolutely one of the more exciting advances I've seen in cancer therapy in the last 20 years," said Dr. David Porter, a hematologist and oncologist at Penn. Essentially, researchers are trying to train Nick's body to fight off cancer in much the same way our bodies fight off the common cold.